%0 Journal Article
%T Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia
%A Ahmed H. Al-jedai
%A Mai F. Alsaqa¡¯aby
%A Noura Khreis
%A Thamer Al Khairallah
%A Varun Vaidya
%J Archive of "Annals of Saudi Medicine".
%D 2017
%R 10.5144/0256-4947.2017.433
%X Promising clinical and humanistic outcomes are associated with the use of new oral agents in the treatment of relapsing-remitting multiple sclerosis (RRMS). This is the first cost-effectiveness study comparing these medications in Saudi Arabia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074120/